Poland is growing faster then other EU countries and there is good base to build a winning life science cluster. ±€5 bil in pharma/y, ±€1bil in medical devices/y, 8000 local life science companies, about 1000 Hospitals and 20k clinics or 6H beds /000 (2x than the USA and 1.5x then CH) is a good start. Bioengineering MSc degrees are issued in english in more than one University and this adds more skills and specialized staff in the market; however all this needs a boost as there is yet not enough concentration of interconnected businesses, free contractors, associated institutions and startup wins to evidence a clear self regeneration. Some of Poland new round of grants (±€5 bil /year in development) could help if intentionally directed to this sector and partially adapted to the special requirements life science early stage projects need to achieve commercialization.
Formed LYNX PBV: a Consulting Company exclusively serving as Director of Investments at BSD GROWTH to be set up as a self managed fund based in Gibraltar. LYNX PBV role will be to recommend investments of the BSD GROWTH Fund and then escort the targeted companies from as early as a post proof of concept (POC) stage into an exit; its services also include improving business registration for entrepreneurs, streamlining the process for transferring property, reducing the time required to enforce contracts, and minimizing insolvency. http://lynxpbv.com/
Yigal Erlich, Adam Broncel and David Vita @ Bioforum in Lodz 2016